A. Lepäntalo

Individual variation in in vitro efficacy of antiplatelet medication - aspirin and clopidogrel

A. Lepäntalo, 2007 .

Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.

R. Lassila, P. Karhunen, J. Reséndiz, 2009, Thrombosis Research.

Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions.

J. Heikkilä, R. Lassila, A. Lepäntalo, 2004, European heart journal.

Comparing modular and personal service delivery in specialised outpatient care: A survey of haematology and oncology patient preferences

P. Torkki, A. Peltokorpi, M. Kaila, 2019, Health services management research.

Polymorphisms of COX-1 and GP VI associate with the antiplatelet effect of aspirin in coronary artery disease patients

J. Backman, R. Lassila, P. Karhunen, 2006, Thrombosis and Haemostasis.

Characterisation of healthcare utilisation and cost of haemophilia care in real‐life: A 4‐year follow‐up study in Finland

T. Siitonen, J. Jokelainen, Outi K. Laine, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Changes in hemostasis parameters in nonfatal methicillin‐sensitive Staphylococcus aureus bacteremia complicated by endocarditis or thromboembolic events: a prospective gender‐age adjusted cohort study

A. Järvinen, E. Forsblom, A. Lepäntalo, 2019, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Diabetes care for patients with peripheral arterial disease.

M. Lepäntalo, M. Heikkinen, M. Salmenperä, 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Individual variation in in vitro efficacy of antiplatelet medication - aspirin and clopidogrel

A. Lepäntalo, 2007 .

Modularising outpatient care delivery: A mixed methods case study at a Finnish University Hospital

P. Torkki, A. Peltokorpi, M. Kaila, 2018, Health services management research.

Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.

R. Lassila, P. Karhunen, J. Reséndiz, 2009, Thrombosis research.